PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Not Yet Opened 06-13 16:00:00 EDT

4.30

+0.06

+1.47%

High4.40	Low4.30	Vol1.61K
Open4.30	D1 Closing4.24	Amplitude2.36%
Mkt Cap20.63M	Tradable Cap7.28M	Total Shares4.80M
T/O6.98K	T/O Rate0.09%	Tradable Shares1.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":4.3,"timestamp":1718308800000,"preClose":4.2377,"halted":0,"volume":1607,"delay":0,"floatShares":1692998,"shares":4797252,"eps":-10.110125,"marketStatus":"Not Yet Opened","change":0.0623,"latestTime":"06-13 16:00:00 EDT","open":4.3,"high":4.4,"low":4.3,"amount":6983.7445,"amplitude":0.023598,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.110125,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1718352000000},"marketStatusCode":0,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":4.2377,"volumeRatio":4.788438,"impliedVol":3.8487,"impliedVolPercentile":0.1127},"requestUrl":"/m/hq/s/PYPD/wiki","defaultTab":"wiki","newsList":[{"id":"2442184868","title":"PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2442184868","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2442184868?lang=en_us&edition=fundamental","pubTime":"2024-06-10 19:00","pubTimestamp":1718017200,"startTime":"0","endTime":"0","summary":"Charles E. Edmiston, Ph.D., Emeritus Professor of Surgery, Medical College of Wisconsin, to discuss the significant unmet medical need in surgical site infections preventionCompany to Provide an Updat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/10/2895869/0/en/PolyPid-to-Host-Virtual-KOL-Event-on-June-17-2024-and-Provide-an-Update-on-the-Company-s-Ongoing-D-PLEX-Phase-3-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4585","BK4181","PYPD","KOL","BK4588","BK4007","HST","CDC"],"gpt_icon":0},{"id":"2435516410","title":"Intensity Therapeutics: A Bargain For A Late-Stage Company With A Remarkable Oncology Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2435516410","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435516410?lang=en_us&edition=fundamental","pubTime":"2024-05-14 21:38","pubTimestamp":1715693911,"startTime":"0","endTime":"0","summary":"Mid-2024, Intensity Therapeutics will start Phase 3 and Phase 2/3 trials respectively in soft tissue sarcoma and triple-negative breast cancer.INT230-6 has shown up to 95% tumor necrosis, prolonged su","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344723902/image_1344723902.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344723902/image_1344723902.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4693038-intensity-therapeutics-a-bargain-for-a-late-stage-company-with-a-remarkable-oncology-drug","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["PYPD","IE00BJJMRZ35.SGD","IE00B7SZLL34.SGD","SG9999002224.SGD","INTS","LU1670710661.SGD","LU1244550221.USD","IE00BFTCPJ56.SGD","NKTX","LU0868494617.USD","SG9999013999.USD","LU1430594728.SGD","SG9999014567.USD","IE00BLSP4452.SGD","JNJ","LU1221951046.USD","LU0266013472.USD","LU0466842654.USD","LU0889566641.SGD","SG9999001440.SGD","SG9999002232.USD","MRK","LU0320765489.SGD","LU0965509010.AUD","BMY","LENZ","LU0912757837.SGD","LU2361045086.USD","LU2125154778.USD","LU0238689110.USD","LU0795875086.SGD","AGEN","IE00BJT1NW94.SGD","BK4516","IE0009355771.USD","PRTG","KRYS","SSI","LU2468319806.SGD","LU1732799900.SGD","LU1291159041.SGD","LU1989771016.USD","LU1221951129.SGD","LU0321505439.SGD","LU0965509283.SGD","LU0965509101.SGD","FATE","LU2602419157.SGD","LU1057294990.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2433773811","title":"Analysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Cartesian Therapeutics (RNAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2433773811","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433773811?lang=en_us&edition=fundamental","pubTime":"2024-05-08 23:32","pubTimestamp":1715182331,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PolyPid (PYPD – Research Report) and Cartesian Thera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-polypid-pypd-and-cartesian-therapeutics-rnac?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-polypid-pypd-and-cartesian-therapeutics-rnac?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","HCSG","RNAC","BK4007","PYPD"],"gpt_icon":0},{"id":"2433974191","title":"PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2433974191","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433974191?lang=en_us&edition=fundamental","pubTime":"2024-05-08 11:00","pubTimestamp":1715137200,"startTime":"0","endTime":"0","summary":"More Than 200 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial ofD-PLEX100for the Prevention of Abdominal Colorectal Surgical Site Infections Approximately 50 Centers Currently Open Unblinded Inte","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/08/2877672/0/en/PolyPid-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":-0.1065},{"period":"3month","weight":-0.2281},{"period":"6month","weight":0.0018},{"period":"1year","weight":-0.6625},{"period":"ytd","weight":0.1152}],"compareEarnings":[{"period":"1week","weight":0.0125},{"period":"1month","weight":0.0393},{"period":"3month","weight":0.0513},{"period":"6month","weight":0.1535},{"period":"1year","weight":0.2398},{"period":"ytd","weight":0.139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.121115},{"month":2,"riseRate":0.25,"avgChangeRate":-0.045621},{"month":3,"riseRate":0.25,"avgChangeRate":-0.070738},{"month":4,"riseRate":0.5,"avgChangeRate":-0.03917},{"month":5,"riseRate":0.5,"avgChangeRate":0.003304},{"month":6,"riseRate":0,"avgChangeRate":-0.076695},{"month":7,"riseRate":0.25,"avgChangeRate":-0.061925},{"month":8,"riseRate":0.5,"avgChangeRate":0.011389},{"month":9,"riseRate":0,"avgChangeRate":-0.391972},{"month":10,"riseRate":0,"avgChangeRate":-0.108855},{"month":11,"riseRate":0.5,"avgChangeRate":0.022832},{"month":12,"riseRate":0,"avgChangeRate":-0.157929}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction